Truist Securities Maintains Hold on PROCEPT BioRobotics, Raises Price Target to $24

Benzinga · 4d ago
Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Hold and raises the price target from $21 to $24.